Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Conmed (CNMD) Tax Provisions (2016 - 2026)

Conmed filings provide 17 years of Tax Provisions readings, the most recent being $4.5 million for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 176.71% to $4.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.0 million, a 1.59% increase, with the full-year FY2025 number at $24.1 million, down 21.38% from a year prior.
  • Tax Provisions hit $4.5 million in Q1 2026 for Conmed, down from $12.5 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $74.8 million in Q2 2022 to a low of -$37.1 million in Q4 2022.
  • Median Tax Provisions over the past 5 years was $4.5 million (2026), compared with a mean of $5.0 million.
  • The widest YoY moves for Tax Provisions: up 2396.16% in 2022, down 1321.92% in 2022.
  • Conmed's Tax Provisions stood at -$37.1 million in 2022, then soared by 120.51% to $7.6 million in 2023, then increased by 29.89% to $9.9 million in 2024, then grew by 26.57% to $12.5 million in 2025, then plummeted by 63.82% to $4.5 million in 2026.
  • The last three reported values for Tax Provisions were $4.5 million (Q1 2026), $12.5 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.